Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway

Acta Pharmacol Sin. 2012 May;33(5):691-700. doi: 10.1038/aps.2012.24. Epub 2012 Apr 30.

Abstract

Aim: To investigate the role of Hedgehog (Hh) signaling pathway in the invasion and metastasis of human hepatocellular carcinoma (HCC).

Methods: Eighty six HCC tissues samples and HCC cell line Bel-7402 were examined. The protein expression of sonic hedgehog (Shh), nuclear glioma-associated oncogene-1 (Gli1), MMP-9 and p-ERK1/2 in HCC was analyzed using immunohistochemistry and Western blot analysis. Boyden chamber assay and wound-healing assay were used to quantify the invasion and metastasis of Bel-7402 cells.

Results: In 86 HCC tissue samples, the positive ratio of Shh and nucleus Gli1 was 67.44% (58/86) and 60.47% (52/86), respectively; the expression of nucleus Gli1 was correlated with the tumor pathological grade (P=0.034), and with the ability of the tumor to invade and metastasize (P=0.001); the expression of nucleus Gli1 was also correlated with p-ERK1/2 (P=0.031) and with MMP-9 (P=0.034). Neither Shh, nor nucleus Gli1 was observed in normal liver tissue. KAAD-cyclopamine (KAAD-cyc), a specific inhibitor of the Hh pathway, at the concentrations of 1 and 4 μmol/L inhibited the invasion and migration of Bel-7402 cells and decreased the expression of Gli1 in nucleus and MMP-9, p-ERK1/2 proteins in Bel-7402 cells. On the other hand, Shh, a ligand of the Hh pathway, at the concentration of 0.5 μg/mL produced opposite effects. The MAPK pathway inhibitors U0126 and PD98059 at the concentrations of 5 and 10 μmol/L inhibited invasion and metastasis of Bel-7402 cells induced by Shh, and decreased the expression of p-ERK1/2 and MMP-9. However, U0126 and PD98059 had no effect on the expression of Gli1.

Conclusion: Hh signaling pathway mediates invasion and metastasis of human HCC by up-regulating the protein expression of MMP-9 via ERK pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blotting, Western
  • Butadienes / pharmacology
  • Carcinoma, Hepatocellular / enzymology*
  • Carcinoma, Hepatocellular / secondary
  • Cell Line, Tumor
  • Cell Movement* / drug effects
  • Cinnamates / pharmacology
  • Dose-Response Relationship, Drug
  • Female
  • Flavonoids / pharmacology
  • Hedgehog Proteins / antagonists & inhibitors
  • Hedgehog Proteins / metabolism*
  • Humans
  • Immunohistochemistry
  • Liver Neoplasms / enzymology*
  • Liver Neoplasms / pathology
  • MAP Kinase Signaling System* / drug effects
  • Male
  • Matrix Metalloproteinase 9 / metabolism
  • Middle Aged
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • Neoplasm Grading
  • Neoplasm Invasiveness
  • Nitriles / pharmacology
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • Transcription Factors / metabolism
  • Veratrum Alkaloids / pharmacology
  • Zinc Finger Protein GLI1

Substances

  • 3-keto-N-aminoethylaminoethylcaproyldihydrocinnamoyl cyclopamine
  • Butadienes
  • Cinnamates
  • Flavonoids
  • GLI1 protein, human
  • Hedgehog Proteins
  • Nitriles
  • Protein Kinase Inhibitors
  • SHH protein, human
  • Transcription Factors
  • U 0126
  • Veratrum Alkaloids
  • Zinc Finger Protein GLI1
  • MAPK1 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Matrix Metalloproteinase 9
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one